title: Parenteral artesunate access programme aims at reducing malaria fatality rates in South Africa.
authors.affiliation: Division of Clinical Pharmacology, Department of Medicine, University of Cape Town.
authors.forename: E Visser
authors.initials: EV
authors.lastname: Kift
authors.forename: T
authors.initials: T
authors.lastname: Kredo
authors.forename: K I
authors.initials: KI
authors.lastname: Barnes
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use*; D037621:Artemisinins / Q000008:administration & dosage / Q000627:therapeutic use*; D000077332:Artesunate; D005260:Female; D006297:Health Services Accessibility / Q000458:organization & administration*; D006801:Humans; D007263:Infusions, Parenteral; D008288:Malaria / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D013019:South Africa; D055815:Young Adult
chemical_list: D000962:Antimalarials; D037621:Artemisinins; D000077332:Artesunate